203 related articles for article (PubMed ID: 30643055)
1. [Research progress in epigenetic studies on systemic sclerosis].
Long Y; Chen W; Du Q; Zuo X; Zhu H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 43(12):1369-1375. PubMed ID: 30643055
[TBL] [Abstract][Full Text] [Related]
2. Epigenetics, the holy grail in the pathogenesis of systemic sclerosis.
Altorok N; Almeshal N; Wang Y; Kahaleh B
Rheumatology (Oxford); 2015 Oct; 54(10):1759-70. PubMed ID: 24740406
[TBL] [Abstract][Full Text] [Related]
3. Unfolding the pathogenesis of scleroderma through genomics and epigenomics.
Tsou PS; Sawalha AH
J Autoimmun; 2017 Sep; 83():73-94. PubMed ID: 28526340
[TBL] [Abstract][Full Text] [Related]
4. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts.
Wang Y; Fan PS; Kahaleh B
Arthritis Rheum; 2006 Jul; 54(7):2271-9. PubMed ID: 16802366
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic factors as drivers of fibrosis in systemic sclerosis.
Bergmann C; Distler JH
Epigenomics; 2017 Apr; 9(4):463-477. PubMed ID: 28343418
[TBL] [Abstract][Full Text] [Related]
6. Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential.
Tsou PS; Varga J; O'Reilly S
Nat Rev Rheumatol; 2021 Oct; 17(10):596-607. PubMed ID: 34480165
[TBL] [Abstract][Full Text] [Related]
7. Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directions.
Miao CG; Xiong YY; Yu H; Zhang XL; Qin MS; Song TW; Du CL
Int Immunopharmacol; 2015 Sep; 28(1):626-33. PubMed ID: 26241784
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic mechanisms: An emerging role in pathogenesis and its therapeutic potential in systemic sclerosis.
Luo Y; Wang Y; Shu Y; Lu Q; Xiao R
Int J Biochem Cell Biol; 2015 Oct; 67():92-100. PubMed ID: 26043891
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Control of Scleroderma: Current Knowledge and Future Perspectives.
Tsou PS
Curr Rheumatol Rep; 2019 Dec; 21(12):69. PubMed ID: 31813068
[TBL] [Abstract][Full Text] [Related]
10. Systemic sclerosis.
Asano Y
J Dermatol; 2018 Feb; 45(2):128-138. PubMed ID: 29226387
[TBL] [Abstract][Full Text] [Related]
11. New insights into the genetics and epigenetics of systemic sclerosis.
Angiolilli C; Marut W; van der Kroef M; Chouri E; Reedquist KA; Radstake TRDJ
Nat Rev Rheumatol; 2018 Nov; 14(11):657-673. PubMed ID: 30305700
[TBL] [Abstract][Full Text] [Related]
12. The Epigenetic Regulation of Scleroderma and Its Clinical Application.
Luo Y; Xiao R
Adv Exp Med Biol; 2020; 1253():375-403. PubMed ID: 32445102
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics and systemic sclerosis.
Altorok N; Kahaleh B
Semin Immunopathol; 2015 Sep; 37(5):453-62. PubMed ID: 26162437
[TBL] [Abstract][Full Text] [Related]
14. Genetic and epigenetic abnormalities in systemic sclerosis.
Makino T; Jinnin M
J Dermatol; 2016 Jan; 43(1):10-8. PubMed ID: 26782002
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic Roles of Autoantibodies and Aberrant Epigenetic Regulation of Immune and Connective Tissue Cells in the Tissue Fibrosis of Patients with Systemic Sclerosis.
Tsai CY; Hsieh SC; Wu TH; Li KJ; Shen CY; Liao HT; Wu CH; Kuo YM; Lu CS; Yu CL
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349208
[TBL] [Abstract][Full Text] [Related]
16. The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis.
Dees C; Schlottmann I; Funke R; Distler A; Palumbo-Zerr K; Zerr P; Lin NY; Beyer C; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2014 Jun; 73(6):1232-9. PubMed ID: 23698475
[TBL] [Abstract][Full Text] [Related]
17. [Systemic sclerosis. Part 2. Epigenetic factors in the pathogenesis of clinical manifestations].
Fryc J; Midro AT; Panasiuk B; Sierakowski S
Przegl Lek; 2015; 72(1):25-30. PubMed ID: 26076574
[TBL] [Abstract][Full Text] [Related]
18. Early inflammatory players in cutanous fibrosis.
Raker V; Haub J; Stojanovic A; Cerwenka A; Schuppan D; Steinbrink K
J Dermatol Sci; 2017 Sep; 87(3):228-235. PubMed ID: 28655471
[TBL] [Abstract][Full Text] [Related]
19. Epigenetics and pathogenesis of systemic sclerosis; the ins and outs.
Aslani S; Sobhani S; Gharibdoost F; Jamshidi A; Mahmoudi M
Hum Immunol; 2018 Mar; 79(3):178-187. PubMed ID: 29330110
[TBL] [Abstract][Full Text] [Related]
20. Epigenomics and transcriptomics of systemic sclerosis CD4+ T cells reveal long-range dysregulation of key inflammatory pathways mediated by disease-associated susceptibility loci.
Li T; Ortiz-Fernández L; Andrés-León E; Ciudad L; Javierre BM; López-Isac E; Guillén-Del-Castillo A; Simeón-Aznar CP; Ballestar E; Martin J
Genome Med; 2020 Sep; 12(1):81. PubMed ID: 32977850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
